Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas

Biochemical and Biophysical Research Communications

Volumn 443, Issue 4, 2014, Pages 1141-1147

  Seki, Yasuhiro ^a,b   Yoshida, Yukihiro ^c,d   Ishimine, Hisako ^b,e   Shinozaki Ushiku, Aya ^d   Ito, Yoshimasa ^b   Sumitomo, Kenya ^f   Nakajima, Jun ^d   Fukayama, Masashi ^d   Michiue, Tatsuo ^a   Asashima, Makoto ^a,b,e   Kurisaki, Akira ^b,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c ASAHI GENERAL HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f JA Kochi Hospital   (India)

Author keywords

Biomarker; Bronchioloalveolar carcinoma; Cell proliferation; Lipase member H; Lung adenocarcinoma; Prognostic marker

Indexed keywords

LIPASE MEMBER H; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; DNA MICROARRAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG ALVEOLUS EPITHELIUM; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

BIOMARKER; BRONCHIOLOALVEOLAR CARCINOMA; CELL PROLIFERATION; LIPASE MEMBER H; LUNG ADENOCARCINOMA; PROGNOSTIC MARKER;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84893736951     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.106     Document Type: Article

References (28)

1. J. Ferlay, H.R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2008 2893 2917
2. J. Subramanian, and R. Govindan Lung cancer in never smokers: a review J. Clin. Oncol. 25 2007 561 570 (Pubitemid 350002964)
3. J.G. Paez, P.A. Janne, and J.C. Lee et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500 (Pubitemid 38720929)
4. T.J. Lynch, D.W. Bell, and R. Sordella et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139 (Pubitemid 38637993)
5. M. Soda, Y.L. Choi, and M. Enomoto et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566 (Pubitemid 47206930)
6. J. Qian, and P.P. Massion Role of chromosome 3q amplification in lung cancer J. Thorac. Oncol. 3 2008 212 215 (Pubitemid 351654319)
7. T. Kikuchi, Y. Daigo, and T. Katagiri et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs Oncogene 22 2003 2192 2205 (Pubitemid 36539569)
8. R. Kuner, T. Muley, and M. Meister et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes Lung Cancer 63 2009 32 38
9. Y. Seki, A. Kurisaki, and K. Watanabe-Susaki et al. TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner Proc. Natl. Acad. Sci. USA 107 2010 10926 10931
10. K. Hibi, B. Trink, and M. Patturajan et al. AIS is an oncogene amplified in squamous cell carcinoma Proc. Natl. Acad. Sci. USA 97 2000 5462 5467 (Pubitemid 30313741)
11. H. Yamamoto, H. Shigematsu, and M. Nomura et al. PIK3CA mutations and copy number gains in human lung cancers Cancer Res. 68 2008 6913 6921
12. A.J. Bass, H. Watanabe, C.H. Mermel, and S. Yu et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Nat. Genet. 41 2009 1238 1242
13. C. Luk, M.S. Tsao, and J. Bayani et al. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization Cancer Genet. Cytogenet. 125 2001 87 99 (Pubitemid 32448052)
14. M. Brunelli, E. Bria, and A. Nottegar et al. True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs PLoS ONE 7 2012 e49689
15. G.M. Newnham, M. Conron, and S. McLachlan et al. Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer BMC Cancer 11 2011 93
16. H. Sonoda, J. Aoki, and T. Hiramatsu et al. A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid J. Biol. Chem. 277 2002 34254 34263
17. W. Jin, U.C. Broedl, and H. Monajemi et al. Lipase H, a new member of the triglyceride lipase family synthesized by the intestine Genomics 80 2002 268 273 (Pubitemid 34985016)
18. J. Aoki, A. Inoue, and S. Okudaira Two pathways for lysophosphatidic acid production Biochim. Biophys. Acta 1781 2008 513 518
19. W.H. Moolenaar Development of our current understanding of bioactive lysophospholipids Ann. N. Y. Acad. Sci. 905 2000 1 10 (Pubitemid 30255400)
20. R. Rivera, and J. Chun Biological effects of lysophospholipids Rev. Physiol. Biochem. Pharmacol. 160 2008 25 46
21. G.B. Mills, and W.H. Moolenaar The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3 2003 582 591 (Pubitemid 37328830)
22. A.J. Houben, and W.H. Moolenaar Autotaxin and LPA receptor signaling in cancer Cancer Metastasis Rev. 30 2011 557 565
23. F. Hao, M. Tan, and X. Xu et al. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38 alpha Biochim. Biophys. Acta 1771 2007 883 892 (Pubitemid 46891301)
24. D. Shida, T. Watanabe, and J. Aoki et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer Lab. Invest. 84 2004 1352 1362 (Pubitemid 40063699)
25. J. Madsen, I. Tornoe, and O. Nielsen et al. Expression and localization of lung surfactant protein A in human tissues Am. J. Respir. Cell Mol. Biol. 29 2003 591 597 (Pubitemid 37357710)
26. T. Ueno, S. Linder, and G. Elmberger Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma Br. J. Cancer 88 2003 1229 1233 (Pubitemid 36606338)
27. T. Hirano, Y. Gong, and K. Yoshida et al. Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma Lung Cancer 41 2003 155 162 (Pubitemid 36842778)
28. L. Galluzzi, A. Goubar, and K.A. Olaussen et al. Prognostic value of LIPC in non-small cell lung carcinoma Cell Cycle 12 2013 647 654